About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Ziprasidone in the Psychosis Prodrome

NCT00635700·11 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Yale University

Age

16–40

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Structured Interview for Psychosis-risk Syndromes criteria for Clinical High Risk for Psychosis
clinically referred

You may not be if

prolonged corrected QT interval
history of syncope

The record

StatusCompleted

PhasePhase 2

Taking part51

StartedMar 2008

UpdatedMar 27, 2023

Conditions

Psychosis Prodrome

Where11

University of California at San Diego
La Jolla, California, United States
University of California at Los Angeles
Los Angeles, California, United States
University of California, San Francisco
San Francisco, California, United States

Clareo Health | Ziprasidone in the Psychosis Prodrome